Picture of Dermapharm Holding SE logo

DMP — Dermapharm Holding SE News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Brief: Dermapharm 9M Adjusted EBITDA EUR 240.3 Million

Nov 14 (Reuters) - Dermapharm 9M EBITDA margin 26.3%.
* 9M adjusted EBITDA margin 27%
* 9M revenue EUR 890.1 million
* 9M EBITDA EUR 234.1 million

Recent news on Dermapharm Holding SE

See all news